Copanlisib dihydrochloride
CAS No. 1402152-13-9
Copanlisib dihydrochloride ( BAY 80-6946 dihydrochloride )
Catalog No. M23560 CAS No. 1402152-13-9
Copanlisib dihydrochloride is an ATP-competitive pan-class I PI3K inhibitor (IC50s: 0.5 nM, 0.7 nM, 3.7 nM and 6.4 nM for PI3Kα, PI3Kδ, PI3Kβ and PI3Kγ).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 42 | In Stock |
|
10MG | 65 | In Stock |
|
25MG | 115 | In Stock |
|
50MG | 200 | In Stock |
|
100MG | 335 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCopanlisib dihydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionCopanlisib dihydrochloride is an ATP-competitive pan-class I PI3K inhibitor (IC50s: 0.5 nM, 0.7 nM, 3.7 nM and 6.4 nM for PI3Kα, PI3Kδ, PI3Kβ and PI3Kγ).
-
DescriptionCopanlisib dihydrochloride is an ATP-competitive pan-class I PI3K inhibitor (IC50s: 0.5 nM, 0.7 nM, 3.7 nM and 6.4 nM for PI3Kα, PI3Kδ, PI3Kβ and PI3Kγ). Copanlisib dihydrochloride has superior antitumor activity and it also has more than 2,000-fold selectivity against other lipid and protein kinases, except for mTOR.
-
SynonymsBAY 80-6946 dihydrochloride
-
PathwayPI3K/Akt/mTOR signaling
-
TargetPI3K
-
RecptorPI3Kα;PI3Kδ;PI3Kβ;PI3Kγ;mTOR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1402152-13-9
-
Formula Weight553.4
-
Molecular FormulaC23H30Cl2N8O4
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESO=C(C1=CN=C(N)N=C1)NC2=NC3=C(C=CC(OCCCN4CCOCC4)=C3OC)C5=NCCN25.[H]Cl.[H]Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Liu N, et al. Mol Cancer Ther. 2013, 12(11), 2319-2330.
molnova catalog
related products
-
TGX-221
A potent, selective PI3K p110β inhibitor with IC50 of 8.5 nM.
-
PI3Kα-IN-243
A potent PI3Kα inhibitor with IC50 of <0.1 uM; also inhibits HDAC (IC50=0.1-1 uM).
-
PI3K-IN-8q
PI3K-IN-8q is a potent, selective dual p110α/p110δ inhibitor with Ki app of 3.3/8.36 nM respectively.